The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ovcharenko D.V.

Moscow Regional Research Institute of Obstetrics and Gynecology

Popov A.A.

Moscow Regional Research Institute of Obstetrics and Gynecology;
Moskvorechye Clinic

Koval’ A.A.

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Tyurina S.S.

Moscow Regional Research Institute of Obstetrics and Gynecology

Fedorov A.A.

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

The effect of nutrients on metabolic disorders associated with polycystic ovary syndrome

Authors:

Ovcharenko D.V., Popov A.A., Koval’ A.A., Tyurina S.S., Fedorov A.A.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2020;20(4): 27‑33

DOI: 10.17116/rosakush20202004127

Read: 17974 times

Download PDF (RU)
Contact the author
Table of contents

THE EFFECT OF NUTRIENTS ON METABOLIC DISORDERS ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME
THE EFFECT OF NUTRIENTS ON METABOLIC DISORDERS ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME

To cite this article:

Ovcharenko DV, Popov AA, Koval’ AA, Tyurina SS, Fedorov AA. The effect of nutrients on metabolic disorders associated with polycystic ovary syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2020;20(4):27‑33. (In Russ.)
https://doi.org/10.17116/rosakush20202004127

Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Modern aspe­cts of gestational diabetes mellitus: defi­nition, risk factors. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):35-41
«Metabolic health» and endo­thelial function in women with poly­cystic ovary syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):27-34
Identification of prognostic significant markers of early diagnosis of obesity and meta­bolic diso­rders. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):71-79
Effe­ctiveness of using preventive and personalized technologies for obesity correction. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):80-90
Features of the course of indu­ced pregnancy during the transfer of a thawed embryo in women with poly­cystic ovary syndrome. Russian Journal of Human Reproduction. 2025;(1):54-62
Obesity in the context of the «old friends» hypo­thesis. Russian Journal of Preventive Medi­cine. 2025;(4):136-141
Prospects for treating Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):54-60
Triglycerides-Glucose Index as an inte­gral biomarker of insu­lin resi­stance and cardiovascular diseases. Russian Journal of Preventive Medi­cine. 2025;(5):124-129
Drinking mine­ral water for progressive resi­stance to insu­lin. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(2):24-30
Pharmacotherapy of the meta­bolically asso­ciated fatty liver disease. Russian Journal of Preventive Medi­cine. 2025;(10):103-108
Abstract:

Polycystic ovary syndrome is a complex heterogeneous disease, the etiology of which is still poorly understood. According to numerous studies, insulin resistance and hyperandrogenism play a central role in the progression of polycystic ovary syndrome. It is believed that many nutrients (vitamins, minerals, and some other supplements) are involved in the signaling pathway of insulin and the synthesis of androgens. In this regard, one of the reasons for the development of polycystic ovary syndrome may be vitamin or mineral deficiency.

Keywords:

polycystic ovary syndrome
insulin resistance
hyperandrogenism
nutrients
metabolic disorders

Authors:

Ovcharenko D.V.

Moscow Regional Research Institute of Obstetrics and Gynecology

Popov A.A.

Moscow Regional Research Institute of Obstetrics and Gynecology;
Moskvorechye Clinic

Koval’ A.A.

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Tyurina S.S.

Moscow Regional Research Institute of Obstetrics and Gynecology

Fedorov A.A.

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Received:

17.02.2020

Accepted:

05.03.2020

Close metadata

References:

  1. Ricardo Azziz, Enrico Carmina, ZiJiang Chen, Andrea Dunaif, Joop S. E. Laven, Richard S. Legro, Daria Lizneva, Barbara Natterson‐Horowtiz, Helena J. Teede and Bulent O. Yildiz. Polycystic ovary syndrome. Nature Reviews Disease Primers. 2016;2:1-18.  https://doi.org/10.1038/nrdp.2016.57
  2. Chan JL, Kar S, Vanky E, Morin-Papupen L, Piltonen T, Puurunen J, Tapanainen J, Maciel G, Hayashida S, Soares J, Baracat E, Mellembakken J, Dokras A. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study. Am J Obstet Gynecol. 2017;217:189:1-8.  https://doi.org/10.1016/j.ajog.2017.04.007
  3. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1-13.  https://doi.org/10.2147/CLEP.S37559
  4. Carmina E. Genetic and environmental aspect of polycystic ovary syndrome. J Endocrinol Invest. 2003;26:1151-1159. https://doi.org/10.1007/BF03345266
  5. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33:981-1030. https://doi.org/10.1210/er.2011-1034
  6. Manukhin IB, Tumilovich LG, Gevorkyan MA. Clinical lectures on gynecological endocrinology. 2006;2:340. (In Russ.).
  7. Matsneva IA, Bakhtiyarov KR, Bogacheva NA, Golubenko EO, Pereverzina NO. Systemic inflammation and insulin resistance in polycystic ovary syndrome. Zhurnal «Zdorov’e i obrazovanie v XXI veke». 2018;20:3:77-83. (In Russ.).
  8. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005; 352:1223-1236. https://doi.org/10.1056/NEJMra041536
  9. Kahn CR. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 1994;43:1066-1084. https://doi.org/10.2337/diab.43.8.1066
  10. Yu J, Yaba A, Kasiman C, Thomson T, Johnson J. mTOR controls ovarian follicle growth by regulating granulosa cell proliferation. PLoS One. 2011;6:21415. https://doi.org/10.1371/journal.pone.0021415
  11. Muscogiuri G, Policola C, Prioletta A, Sorice G, Mezza T, Lassandro A, Della Casa S, Pontecorvi A, Giaccari A. Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? Clin Nutr. 2012;31:4:476-480. 
  12. Thomson RL, Spedding S, Buckley JD. Vitamin D in the etiology and management of polycystic ovary syndrome. Clin Endocrinol. 2012;77:343-350.  https://doi.org/10.1111/j.1365-2265.2012.04434.x
  13. Jakimiuk AJ, Szamatowicz J. The role of inositol deficiency in the etiology of polycystic ovary syndrome disorders. Ginekol Pol. 2014;85:54-57.  https://doi.org/10.17772/gp/1691
  14. Pu Y, Wang Z, Bian Y, Zhang F, Yang P, Li Y, Zhang Y, Liu Y, Fang F, Cao H, Zhang X. All-trans retinoic acid improves goat oocyte nuclear maturation and reduces apoptotic cumulus cells during in vitro maturation. Anim Sci J. 2014;85:833-839.  https://doi.org/10.1111/asj.12216
  15. Deb GK, Dey SR, Bang JI, Lee JG, Kong IK. 9-cis Retinoic acid inhibits cumulus cell apoptosis during the maturation of bovine cumulus-oocyte-complexes. J Anim Sci. 2012;90:1798-1806. https://doi.org/10.2527/jas.2011-4340
  16. Hahn S, Backhaus M, Broecker-Preuss M, Tan S, Dietz T, Kimmig R, Schmidt M, Mann K, Janssen OE. Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism. Eur J Endocrinol. 2007;157:201-207.  https://doi.org/10.1530/EJE-07-0143
  17. Yarali H, Yildirir A, Aybar F, Kabakci G, Bükülmez O, Akgül E, Oto A. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril. 2001;76:511-516.  https://doi.org/10.1016/s0015-0282(01)01937-9
  18. Loverro G, Lorusso F, Mei L, Depalo R, Cormio G, Selvaggi L. The plasma homocysteine levels are increased in polycystic ovary syndrome. Gynecol Obstet Invest. 2002;53:157-162. 
  19. Badawy A, State O, El Gawad S, El Aziz OA. Plasma homocysteine and polycystic ovary syndrome: the missed link. Eur J Obstet Gynecol Reprod Biol. 2007;131:68-72. 
  20. Kaya C, Cengiz SD, Satiroglu H. Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS. Reprod Biomed Online. 2009;19:721-726.  https://doi.org/10.1016/j.rbmo.2009.06.005
  21. Kazerooni T, Asadi N, Dehbashi S, Zolghadri J. Effect of folic acid in women with and without insulin resistance who have hyperhomocysteinemic polycystic ovary syndrome. Int J Gynaecol Obstet. 2008;101:156-160.  https://doi.org/10.1016/j.ijgo.2007.10.024
  22. Randeva HS, Lewandowski KC, Drzewoski J, Brooke-Wavell K, O’Callaghan C, Czupryniak L, Hillhouse EW, Prelevic GM. Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:4496-4501. https://doi.org/10.1210/jc.2001-012056
  23. de Jager J, Kooy A, Lehert P, Wulffele MG, van der Kolk J, Bets D, Verburg J, Donker A, Stehouwer C. Long-term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo-controlled trial. BMJ. 2010;340:2181. https://doi.org/10.1136/bmj.c2181
  24. Kilicdag EB, Bagis T, Zeyneloglu HB, Tarim E, Aslan E, Haydardedeoglu B, Erkanli S. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study. Hum Reprod. 2005;20:894-899.  https://doi.org/10.1093/humrep/deh700
  25. Kilicdag EB, Bagis T, Tarim E, Aslan E, Erkanli S, Simsek E, Haydardedeoglu B, Kuscu E. Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial. Hum Reprod. 2005;20:1521-1528. https://doi.org/10.1093/humrep/deh825
  26. Palomba S, Falbo A, Giallauria F, Russo T, Tolino A, Zullo F, Colao A, Orio F. Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome. Diabetes Care. 2010;33: 246-251.  https://doi.org/10.2337/dc09-1516
  27. Papaleo E, Unfer V, Baillargeon JP, Chiu TT. Contribution of myo-inositol to reproduction. Eur J Obstet Gynecol Reprod Biol. 2009;147:120-123.  https://doi.org/10.1016/j.ejogrb.2009.09.008
  28. Unfer V, Carlomagno G, Dante G, Facchinetti F. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol. 2012;28:509-515.  https://doi.org/10.3109/09513590.2011.650660
  29. Alvarez JA, Ashraf A. Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2010;1-18.  https://doi.org/10.1155/2010/351385
  30. Krul-Poel YH, Snackey C, Louwers Y, Lips P, Lambalk CB, Laven JS, Simsek, S. The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review. Eur J Endocrinol. 2013;169:853-865.  https://doi.org/10.1530/EJE-13-0617
  31. Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG, Kamaci M. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet. 2009;280:559-563.  https://doi.org/10.1007/s00404-009-0958-7
  32. Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G, Tuncel E, Erturk E, Imamoglu S. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest. 2010;33:234-248.  https://doi.org/10.3275/6560
  33. Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG. Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril. 2009;92:1053-1058. https://doi.org/10.1016/j.fertnstert.2008.07.1757
  34. Irani M, Minkoff H, Seifer DB, Merhi Z. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. J Clin Endocrinol Metab. 2014;99:886-890.  https://doi.org/10.1210/jc.2013-4374
  35. Cicek N, Eryilmaz OG, Sarikaya E, Gulerman C, Genc Y. Vitamin E effect on controlled ovarian stimulation of unexplained infertile women. J Assist Reprod Genet. 2012;29:325-328.  https://doi.org/10.1007/s10815-012-9714-1
  36. Izadi A, Ebrahimi S, Shirzai S, Taghizadeh S, Parized M, Farzadi L, Gargari, BP. Hormonal and metabolic effects of coenzyme q10 and/ or vitamin E in patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2019;104:2:319-327.  https://doi.org/10.1210/jc.2018-01221
  37. Ebrahimi FA, Samimi M, Foroozanfard F, Jamilian M, Akbari H, Rahmani E, Ahmadi S, Taghizadeh M, Memarzadeh MR, Asemi Z. The effects of omega-3 fatty acids and vitamin E co-supplementation on indices of insulin resistance and hormonal parameters in patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes. 2017;125:353-359.  https://doi.org/10.1055/s-0042-117773
  38. Homa ST, Carroll J, Swann K. The role of calcium in mammalian oocyte maturation and egg activation. Hum Reprod. 1993;8:1274-1281. https://doi.org/10.1093/oxfordjournals.humrep.a138240
  39. Ullah G, Jung P, Machaca K. Modeling Ca2+ signaling differentiation during oocyte maturation. Cell Calcium. 2007;42:556-564.  https://doi.org/10.1016/j.ceca.2007.01.010
  40. Firouzabadi Rd, Aflatoonian A, Modarresi S, Sekhavat L, Mohammad Taheri, S. Therapeutic effects of calcium & vitamin D supplementation in women with PCOS. Complement Ther Clin Pract. 2012;18:85-88.  https://doi.org/10.1016/j.ctcp.2012.01.005
  41. Anderson RA. Chromium in the prevention and control of diabetes. Diabetes Metab. 2000;26:22-27. 
  42. Lucidi RS, Thyer AC, Easton CA, Holden AE, Schenken RS, Brzyski RG. Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome. Fertil Steril. 2005;84:1755-1757. https://doi.org/10.1016/j.fertnstert.2005.06.028
  43. Jamilian M, Asemi Z. Chromium supplementation and the effects on metabolic status in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Ann Nutr Metab. 2015;67:42-48.  https://doi.org/10.1159/000438465
  44. Amooee S, Parsanezhad ME, Ravanbod Shirazi M, Alborzi S, Samsami A. Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOS: A double-blind randomized clinical trial. Iran J Reprod Med. 2013;11:611-618. 
  45. Amr N, Abdel-Rahim HE. The effect of chromium supplementation on polycystic ovary syndrome in adolescents. J Pediatr Adolesc Gynecol. 2015;28:114-148.  https://doi.org/10.1016/j.jpag.2014.05.005
  46. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam, A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000;294:1-26.  https://doi.org/10.1016/s0009-8981(99)00258-2
  47. Bresink I, Danysz W, Parsons CG, Mutschler E. Different binding affinities of Nmda receptor-channel blockers in various brain-regions — indication of Nmda receptor Heterogeneity. Neuropharmacology. 1995;34:533-540.  https://doi.org/10.1016/0028-3908(95)00017-z
  48. Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses. 2006;67:362-370.  https://doi.org/10.1016/j.mehy.2006.01.047
  49. Song Y, Manson JE, Cook NR, Albert CM, Buring JE, Liu S. Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol. 2005;96:1135-1141.
  50. Young LT, Robb JC, Levitt AJ, Cooke RG, Joffe RT. Serum Mg2+ and Ca2+/Mg2+ ratio in major depressive disorder. Neuropsychobiology. 1996;34:26-28. 
  51. Mirone M, Giannetta E, Isidori AM. Selenium and reproductive function. A systematic review. J Endocrinol Invest. 2013;36:28-36. 
  52. Coskun A, Arikan T, Kilinc M, Arikan DC, Ekerbicer HC. Plasma selenium levels in Turkish women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2013;168:183-186.  https://doi.org/10.1016/j.ejogrb.2013.01.021
  53. Zadeh Modarres S, Heidar Z, Foroozanfard F, Rahmati Z, Aghadavod E, Asemi Z. The effects of selenium supplementation on gene expression related to insulin and lipid in infertile polycystic ovary syndrome women candidate for in vitro fertilization: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res. 2018;183:218-225.  https://doi.org/10.1007/s12011-017-1148-2
  54. Jamilian M, Razavi M, Fakhrie Kashan Z, Ghandi Y, Bagherian T, Asemi Z. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double- blind, placebo-controlled trial. Clin Endocrinol. 2015;82:885-891.  https://doi.org/10.1111/cen.12699
  55. Tubek S. Zinc supplementation or regulation of its homeostasis: advantages and threats. Biol Trace Elem Res. 2007;119:1-9.  https://doi.org/10.1007/s12011-007-0043-7
  56. Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr. 1998; 17:109-115.  https://doi.org/10.1080/07315724.1998.10718735
  57. Bolkent S, Yanardag R, Bolkent S, Mutlu O, Yildirim S, Kangawa K, Minegishi Y, Suzuki H. The effect of zinc supplementation on ghrelin-immunoreactive cells and lipid parameters in gastrointestinal tissue of streptozotocin-induced female diabetic rats. Mol Cell Biochem. 2006;286:77-85. 
  58. Guler I, Himmetoglu O, Turp A, Erdem A, Erdem M, Onan MA, Taskiran C, Taslipinar MY, Guner H. Zinc and homocysteine levels in polycystic ovarian syndrome patients with insulin resistance. Biol Trace Elem Res. 2014;158:297-304.  https://doi.org/10.1007/s12011-014-9941-7
  59. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997; 18:774-800.  https://doi.org/10.1210/edrv.18.6.0318
  60. Beletate V, El Dib RP, Atallah AN. Zinc supplementation for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007;CD005525. https://doi.org/10.1002/14651858.CD005525.pub2
  61. Ahmed Z, Tabrizi S, Li A, Houlden H, Sailer A, Lees AJ. A case of Huntington’s disease phenocopy characterised by pallido-nigro-luysian degeneration with brain-iron accumulation and p62- positive glial inclusions. Eur J Neurol. 2010;17:379. 
  62. Reiter RJ, Tamura H, Tan DX, Xu X. Melatonin and the circadian system: contributions to successful female reproduction. Fertil Steril. 2014;102:2:321-328.  https://doi.org/10.1016/j.fertnstert.2014.06.014
  63. Wei D, Zhang C, Xie J, Song X, Yin B, Liu Q, Hu L, Hao H, Geng J, Wang P. Supplementation with low concentrations of melatonin improves nuclear maturation of human oocytes in vitro. J Assist Reprod Genet. 2013;30:933-938.  https://doi.org/10.1007/s10815-013-0021-2
  64. Tamura H, Nakamura Y, Terron MP, Flores LJ, Manchester LC, Tan DX, Sugino N, Reiter RJ. Melatonin and pregnancy in the human. Reprod Toxicol. 2008;25:291-303.  https://doi.org/10.1016/j.reprotox.2008.03.005
  65. Kim MK, Park EA, Kim HJ, Choi WY, Cho JH, Lee WS, Cha KY, Kim YS, Lee DR, Yoon TK. Does supplementation of in-vitro culture medium with melatonin improve IVF outcome in PCOS? Reprod Biomed Online. 2013;26:22-29.  https://doi.org/10.1016/j.rbmo.2012.10.007
  66. Vargas ML, Almario RU, Buchan W, Kim K, Karakas SE. Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism. 2011;60:1711-1178. https://doi.org/10.1016/j.metabol.2011.04.007
  67. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83:6:1505-1519. https://doi.org/10.1093/ajcn/83.6.1505S
  68. Poudyal H, Panchal SK, Diwan V, Brown L. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res. 2011;50:372-387.  https://doi.org/10.1016/j.plipres.2011.06.003
  69. Shahnazi V, Zaree M, Nouri M, Mehrzad-Sadaghiani M, Fayezi S, Darabi M. Influence of omega-3 fatty acid eicosapentaenoic acid on IGF-1 and COX-2 gene expression in granulosa cells of PCOS women. Iran J Reprod Med. 2015;13:71-78. 
  70. Akinkuolie AO, Ngwa JS, Meigs JB, Djousse L. Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials. Clin Nutr. 2011;30:702-707. 
  71. Samir Softic, Manoj K. Gupta, Guo-Xiao Wang, Shiho Fujisaka, Brian T. O’Neill, Tata Nageswara Rao, Jennifer Willoughby, Carole Harbison, Kevin Fitzgerald, Olga Ilkayeva, Christopher B. Newgard, David E. Cohen, and C. Ronald Kahn. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. J Clin Invest. 2017;127:11:4059-4074. https://doi.org/10.1172/JCI99009
  72. Bei Shi, Di Feng, Matthew Sagnelli, Jiao Jiao, Xiaoli Sun, Xiuxia Wang, and Da Li. Fructose levels are elevated in women with polycystic ovary syndrome with obesity and hyperinsulinemia. Hum Reprod. 2020;35:1:181-194.  https://doi.org/10.1093/humrep/dez239
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.